TERF2 and cancer: Human samples of normal breast tissue (N = 41), benign lesions (N = 51) or malignant tumors (N = 55) surgically treated at Regina Elena National Cancer Institute were analyzed for TRF2 protein expression by IHC analysis (Fig. 5A, B).